Yoshida, Manami
Iwasaki, Kosuke
Miyashita, Mitsunori
Saeki, Toshiaki
Morioka, Yasuhide
Hiroi, Shinzo
Shimizu, Eiko
Article History
Received: 6 January 2023
Accepted: 9 May 2023
First Online: 2 June 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects by the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labor, and Welfare, Japan. Approval was granted by the Ethics Committee of the University of Tokyo (No 31–32).
: Informed consent was waived because the collected data were anonymized for secondary use.
: Manami Yoshida, Yasuhide Morioka, and Shinzo Hiroi are employees of Shionogi & Co., Ltd., and own shares in Shionogi & Co., Ltd. Kosuke Iwasaki is an employee of Milliman Inc., which has received consulting fees from Shionogi & Co., Ltd. Mitsunori Miyashita has no relevant financial or non-financial interests to disclose. Toshiaki Saeki has received grants from Eisai Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Taiho Pharmaceutical Co., Ltd., consulting fees from Ono Pharmaceutical Co., Ltd., and honoraria from Eisai Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Taiho Pharmaceutical Co., Ltd., Pfizer Japan Inc., Eli Lilly Japan K.K., and Chugai Pharmaceutical Co., Ltd. Eiko Shimizu belongs to the Social Cooperation Program of IT Healthcare, Graduate School of Pharmaceutical Sciences, The University of Tokyo, as a project associate professor sponsored by 10 companies, including Shionogi & Co., Ltd., and has received grants from Shionogi & Co., Ltd., Chugai Pharmaceutical Co., Ltd., Neopharma Japan Co., Ltd., 3H Holdings Inc., Cmic Co., Ltd., AstraZeneca K.K., Mitsubishi Tanabe Pharma Corporation, NTT DATA Corporation, SCSK Corporation, and Aflac Life Insurance Japan Ltd.